# FDA 483 - Mission Pharmacal Company - April 04, 2019

Source: https://www.keypedia.com/records/483/mission-pharmacal-company/de4b9fd5-1991-46a8-aef1-60b534e3f5c9

> FDA 483 for Mission Pharmacal Company on April 04, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mission Pharmacal Company
- Inspection Date: 2019-04-04
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Mission Pharmacal Company in Boerne, TX, a drug manufacturer, identified two significant issues. The facility's buildings used for drug manufacturing were not maintained in a good state of repair, exhibiting rust, peeling paint, and other deficiencies. Additionally, the firm's laboratory records were found to be deficient due to a lack of accountability for raw data documented on analytical sheets.

## Related Documents

- [483 - 2012-05-25](https://www.keypedia.com/records/483/mission-pharmacal-company/0baf761c-5141-4187-9f2f-099e78a6b8f1)
- [483 - 2014-02-07](https://www.keypedia.com/records/483/mission-pharmacal-company/4a5b0198-5b64-4f4b-8326-3e1ac06b0f95)
- [483 - 2022-09-22](https://www.keypedia.com/records/483/mission-pharmacal-company/c1fa42f1-b5d4-43b9-a7ab-c65cbe41084c)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/anitha-p-govada/07f94777-660b-4b81-b63c-54f3b4a8635e)
- [Margaret M. Annes](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)

Company: https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9